UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

Movement disorders, 2010-11, Vol.25 (15), p.2649-2653

2010

Volltextzugriff (PDF)

Initiation of pharmacological therapy in Parkinson's disease: when, why, and how

Lancet neurology, 2020-05, Vol.19 (5), p.452-461

2020

Volltextzugriff (PDF)

Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—Reply

JAMA neurology, 2022-07, Vol.79 (7), p.726

2022

Volltextzugriff (PDF)

Physiotherapy for Parkinson's disease: a comparison of techniques

Cochrane database of systematic reviews, 2014-06, Vol.2014 (6), p.CD002815-CD002815

2014

Volltextzugriff (PDF)

Measuring the burden and mortality of hospitalisation in Parkinson's disease: A cross-sectional analysis of the English Hospital Episodes Statistics database 2009–2013

Parkinsonism & related disorders, 2015-05, Vol.21 (5), p.449-454

2015

Volltextzugriff (PDF)

Botulinum toxins for the prevention of migraine in adults

Cochrane library, 2015-04

2015

Volltextzugriff (PDF)

Botulinum toxins for the prevention of migraine in adults

Cochrane database of systematic reviews, 2018-06, Vol.6 (6), p.CD011616

2018

Volltextzugriff (PDF)

Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies

Cochrane database of systematic reviews, 2011-11 (11), p.CD008454

2011

Volltextzugriff (PDF)

Physiotherapy intervention in Parkinson's disease: systematic review and meta-analysis

BMJ (Online), 2012-08, Vol.345 (aug06 1), p.e5004-e5004

International edition, 2012

Volltextzugriff (PDF)

Physiotherapy versus placebo or no intervention in Parkinson's disease

Cochrane database of systematic reviews, 2012-07 (7), p.CD002817

2012

Volltextzugriff (PDF)

Physiotherapy versus placebo or no intervention in Parkinson's disease

Cochrane database of systematic reviews, 2013-09, Vol.2013 (9), p.CD002817

2013

Volltextzugriff (PDF)

Development and validation of the e-Work Self-Efficacy Scale to assess digital competencies in remote working

Computers in human behavior reports, 2021-08, Vol.4, p.100129-100129, Article 100129

2021

Volltextzugriff (PDF)

Initial drug treatment in Parkinson's disease

BMJ (Online), 2015-09, Vol.351, p.h4669

2015

Volltextzugriff (PDF)

Cost‐Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's Disease

Movement disorders, 2021-09, Vol.36 (9), p.2136-2143

2021

Volltextzugriff (PDF)

Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB)

Health technology assessment (Winchester, England), 2016-08, Vol.20 (63), p.1-96

2016

Volltextzugriff (PDF)

Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial

The Lancet (British edition), 2014-09, Vol.384 (9949), p.1196-1205

2014

Volltextzugriff (PDF)

Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial

JAMA neurology, 2016-03, Vol.73 (3), p.291

2016

Volltextzugriff (PDF)

The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCT

Health technology assessment (Winchester, England), 2024-10, Vol.28 (58), p.1-141

2024

Volltextzugriff (PDF)

Idiopathic intracranial hypertension

Lancet neurology, 2006-05, Vol.5 (5), p.433-442

2006

Volltextzugriff (PDF)

Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease

BMJ open, 2014-12, Vol.4 (12), p.e006434-e006434

2014

Volltextzugriff (PDF)

Rotigotine transdermal patch in early Parkinson's disease: A randomized, double-blind, controlled study versus placebo and ropinirole

Movement disorders, 2007-12, Vol.22 (16), p.2398-2404

2007

Volltextzugriff (PDF)

Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?

Movement disorders, 2008-04, Vol.23 (6), p.784-789

Clarke, Carl E.

2008

Volltextzugriff (PDF)

Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine

BMJ open, 2019-07, Vol.9 (7), p.e027953

2019

Volltextzugriff (PDF)

Authors' reply to Braithwaite and Elrington

BMJ (Online), 2015-11, Vol.351, p.h5846

2015

Volltextzugriff (PDF)

1 – 25 von 565

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(432)
Mit Volltextzugriff
(443)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

Initiation of pharmacological therapy in Parkinson's disease: when, why, and how

Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—Reply

Physiotherapy for Parkinson's disease: a comparison of techniques

Measuring the burden and mortality of hospitalisation in Parkinson's disease: A cross-sectional analysis of the English Hospital Episodes Statistics database 2009–2013

Botulinum toxins for the prevention of migraine in adults

Botulinum toxins for the prevention of migraine in adults

Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies

Physiotherapy intervention in Parkinson's disease: systematic review and meta-analysis

Physiotherapy versus placebo or no intervention in Parkinson's disease

Physiotherapy versus placebo or no intervention in Parkinson's disease

Development and validation of the e-Work Self-Efficacy Scale to assess digital competencies in remote working

Initial drug treatment in Parkinson's disease

Cost‐Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's Disease

Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB)

Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial

Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial

The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCT

Idiopathic intracranial hypertension

Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease

Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial

Rotigotine transdermal patch in early Parkinson's disease: A randomized, double-blind, controlled study versus placebo and ropinirole

Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?

Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine

Authors' reply to Braithwaite and Elrington

Aktive Filter

Suchergebnisse filtern